Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,475 | -30,101 | -7,171 | 12,327 | -40,664 |
| Depreciation Amortization | 692 | 3,577 | 2,566 | 1,386 | 693 |
| Other Working Capital | -9,206 | -29,223 | -27,304 | -9,212 | -15,673 |
| Other Operating Activity | 1,814 | -98,609 | -101,479 | -102,801 | 3,771 |
| Operating Cash Flow | $-17,175 | $-154,356 | $-133,388 | $-98,300 | $-51,873 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,000 | 38,850 | 43,088 | 32,862 | -22,213 |
| PPE Investments | N/A | 1,479 | 485 | -638 | -270 |
| Investing Cash Flow | $18,000 | $40,329 | $43,573 | $32,224 | $-22,483 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -108 | -415 | -310 | -205 | -102 |
| Common Stock Issued | N/A | 332 | 462 | 462 | 43 |
| Financing Cash Flow | $-108 | $-83 | $152 | $257 | $-59 |
| Beginning Cash Position | 75,742 | 188,170 | 188,170 | 188,170 | 188,170 |
| End Cash Position | 76,459 | 74,060 | 98,507 | 122,351 | 113,755 |
| Net Cash Flow | $717 | $-114,110 | $-89,663 | $-65,819 | $-74,415 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,175 | -154,356 | -133,388 | -98,300 | -51,873 |
| Capital Expenditure | N/A | -661 | -661 | -638 | -270 |
| Free Cash Flow | -17,175 | -155,017 | -134,049 | -98,938 | -52,143 |